Nxstage Medical (NXTM) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation and amortization	23.97M
Stock-based compensation
Other	-886K
Accounts receivable	-5.5M
Inventory	-22.03M
Prepaid expenses and other assets	621K
Accounts payable	3.93M
Accrued expenses and other liabilities	3.02M
Deferred revenues	-924K
Net cash used in operating activities
Purchases of property and equipment	-6.8M
Net cash used in investing activities
Proceeds from stock option and purchase plans
Purchase of treasury stock
Repayments on loans and lines of credit	-225K
Net cash provided by financing activities
Foreign exchange effect on cash and cash equivalents	559K
Decrease in cash and cash equivalents	1.75M
Cash and cash equivalents, beginning of period	59.07M
Cash and cash equivalents, end of period	60.82M
Transfers from inventory to field equipment
Transfers from field equipment to deferred cost of revenues

Entities mentioned with NXTM

View All Entities